Diagnostics group Eurofins gets US 'EUA' approval for home-based COVID-19 Test

Results are reviewed by a licensed physician and provided via email within 24 hours of sample receipt

Tribune Web Desk

Updated At : 05:27 PM Oct 19, 2020 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Paris, October 19

Laboratory testing and diagnostics company Eurofins said its new at-home COVID nasal testing product had received ‘Emergency Use Approval’ (EUA) status from the US Food & Drug Administration regulatory body.

Eurofins said the EUA authorised self-collection kit gives consumers a convenient and quick option to test from the comfort of their home, with results reviewed by a licensed physician and provided via email within 24 hours of sample receipt.

Worldwide coronavirus cases crossed 40 million on Monday, according to a Reuters tally, as the onset of winter in the northern hemisphere fuelled a resurgence in the spread of the disease. Reuters

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles